Recently, the inaugural meeting of The Ruipu Biological Industry College of Tianjin Vocational University (hereinafter referred to as the Ruipu Biological Industry College) was held in the headquarters of Ruipu Biology. It has opened a new chapter in Tianjin Vocational University's efforts to help the development of Bincheng's biomedical industry, and school-enterprise collaborative education to achieve a win-win situation.
(The scene of the inauguration ceremony of Ruipu Bioindustry College)
(Speech by Shen Jiang, Secretary of the Party Committee of Tianjin Vocational University)
At the inauguration ceremony, Shen Jiang, secretary of the Party Committee of Tianjin Vocational University, said that Ruipu Bio is the largest manufacturer and service provider of animal health products in China that integrates biological vaccines, pharmaceutical raw materials, pharmaceutical preparations and feed additives. The School of Biological and Environmental Engineering of Tianjin Vocational University is the oldest college in the university, and the pharmaceutical production technology major is committed to serving the high-end biomedical industry and the technological upgrading of small and medium-sized enterprises. Through accurate docking, complementary advantages, and joint consultation and co-construction, the two sides will be able to integrate into regional development, promote industrial upgrading, and contribute to the promising dream of vocational education.
(Speech by Tong Yue, Vice President of Rip Biotech)
Tong Yue, vice president of Tianjin Ruipu Biotechnology Co., Ltd., said that the school actively serves the talent needs of the biomedical industry, and has achieved remarkable results in curriculum resource development, talent training and teacher team building, which is highly complementary to enterprises. The establishment of Ruipu Biological Industry College can fully integrate the high-quality resources of both sides, closely focus on the needs of the pharmaceutical industry, and cultivate future drug production talents.
(Opening Ceremony of Rip Bioindustry College of Tianjin Vocational University)
As a technology R&D enterprise deeply engaged in the animal insurance industry, the annual R&D expenditure of Ruipu Bio located in the free trade zone has exceeded 150 million yuan, and the R&D team has exceeded 400 people. At present, in addition to the total suspension technology, Ruipu Bio also has a genetically engineered vaccine technology platform, developed the world's first avian influenza DNA vaccine, making China the second country to master the third generation of vaccine technology after the United States, which is of great significance to China's transformation from a world vaccine power to a vaccine power.